MYL - Mylan N.V.
Close
15.855
0.305 1.924%
Share volume: 0
Last Updated: Mon 16 Nov 2020 10:00:01 PM CET
Pharmaceuticals: Generic:
0.49%
PREVIOUS CLOSE
CHG
CHG%
$15.55
0.31
1.96%
Summary score
81%
Profitability
100%
Dept financing
50%
Liquidity
43%
Performance
80%
Sector
Health Technology
Industry
Pharmaceuticals: Generic
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0.77%
Return on assets
0.92%
Return on sales
10.44%
Return on invested capital
0.42%
Total debt ratio
63.68%
Debt ratio change over timeo
92.73%
Current Ratio
1.29%
Quick Ratio
0.79%
Cash Position Ratio
0.1%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
0.72%
Return on assets
0.93%
Return on sales
9.55%
Return on invested capital
0.43%
Total debt ratio
62.04%
Debt ratio change over timeo
182.21%
Current Ratio
1.19%
Quick Ratio
0.7%
Cash Position Ratio
0.07%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
0.34%
Return on assets
0.52%
Return on sales
5.79%
Return on invested capital
0.24%
Total debt ratio
61.05%
Debt ratio change over time
562.7%
Current Ratio
0.93%
Quick Ratio
0.53%
Cash Position Ratio
0.05%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
119.18%
Return on assets
28.15%
Return on sales
1401.6%
Return on invested capital
29.32%
Total debt ratio
9273.17%
Debt ratio change over time
92.73%
Current Ratio
165.12%
Quick Ratio
100.72%
Cash Position Ratio
11.17%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MYL | AGN | ABEOW | PETX |
|---|---|---|---|---|
| Return on equity | 0.77% | -0.34% | 0% | -10.54% |
| Return on assets | 0.92% | 0.09% | 0% | -5.69% |
| Return on sales | 10.44% | 1.71% | 0% | -3529.01% |
| Return on invested capital | 0.42% | -0.1% | 0% | -43.38% |
| Profitability | 100% | 7% | 0% | 0% |
| Total debt ratio | 63.68% | 37.49% | 0% | 28.72% |
| Debt ratio change over time | 92.73% | -131.92% | 0% | -1.64% |
| Dept financing | 50% | 15% | 0% | 11% |
| Current Ratio | 1.19% | 1% | 0% | 0% |
| Quick Ratio | 0.7% | 0.88% | 0% | 0% |
| Cash Position Ratio | 0.07% | 0.16% | 0% | 0% |
| Liquididy | 14% | 18% | 0% | 75% |
| Short-term ratios | MYL | AGN | ABEOW | PETX |
|---|---|---|---|---|
| Return on equity | 0.72% | -0.41% | 0% | 0% |
| Return on assets | 0.93% | 0.24% | 0% | 0% |
| Return on sales | 9.55% | 5.3% | 0% | 0% |
| Return on invested capital | 0.43% | -0.32% | 0% | 0% |
| Profitability | 100% | 20% | 0% | 0% |
| Total debt ratio | 62.04% | 37.01% | 0% | 0% |
| Debt ratio change over time | 182.21% | -45.17% | 0% | 0% |
| Dept financing | 50% | 15% | 0% | 0% |
| Current Ratio | 1.19% | 1% | 0% | 0% |
| Quick Ratio | 0.7% | 0.88% | 0% | 0% |
| Cash Position Ratio | 0.07% | 0.16% | 0% | 0% |
| Liquididy | 56% | 71% | 0% | 0% |